PUBLISHER: QYResearch | PRODUCT CODE: 2178404
PUBLISHER: QYResearch | PRODUCT CODE: 2178404
Bio-based Dicyclopentadiene (Bio-DCPD) is an industrial chemical intermediate manufactured from renewable biomass, biomass-derived chemical intermediates, or biogenic waste and residue feedstocks, including products with renewable material attributes allocated through certified mass balance supply chains. The compound has the molecular formula C10H12, a molecular weight of approximately 132.20 g/mol, and CAS number 77-73-6. Its fundamental molecular structure and chemical reactivity are equivalent to those of conventional petroleum-derived dicyclopentadiene. Bio-DCPD is primarily produced through renewable-feedstock cracking and C5 recovery, followed by cyclopentadiene dimerization and purification. An alternative manufacturing route involves the multistep chemical conversion of biomass-derived intermediates, including furfural, into cyclopentadiene and ultimately DCPD. Commercial DCPD is supplied in several industrial grades, including resin-grade, industrial-grade, and high-purity products, with representative DCPD concentrations of approximately 80%, 85%, 94%, and above 99%, depending on the manufacturing process and intended application. Critical technical parameters include DCPD purity, residual cyclopentadiene, codimer composition, aromatic impurities, water content, color, storage stability, and compatibility with downstream polymerization catalysts. Bio-DCPD serves as a reactive intermediate for unsaturated polyester resins, hydrocarbon resins, specialty chemical intermediates, poly(dicyclopentadiene) structural materials, and elastomer-related intermediates. The market includes industrial-grade physical bio-based and qualifying mass balance-certified Bio and Bio-circular DCPD products. Conventional fossil-derived DCPD, products carrying exclusively non-biogenic circular attributes, laboratory reagents, and the sales value of downstream resins, polymers, specialty alcohols, and other chemically converted derivatives are excluded. Manufacturers' ex-factory sales constitute the commercial market boundary, without additional counting of distributors' markups or downstream product revenues.
Key Findings
The global Bio-based Dicyclopentadiene (Bio-DCPD) market recorded an estimated sales volume of 771 tons and revenue of USD 2.10 million in 2025. Sales are projected to reach 1,045 tons and USD 2.71 million in 2026, increasing to 36,416 tons and USD 58.79 million by 2032. The corresponding 2026-2032 volume and revenue CAGRs are 80.73% and 67.00%.
The average global ex-factory price of Bio-DCPD was approximately USD 2,724 per ton in 2025. Bio-circular products averaged USD 2,661 per ton, while virgin biomass-based products averaged USD 2,991 per ton, reflecting differences in feedstock sourcing, processing requirements, and product composition.
Bio-circular feedstocks accounted for 80.42% of global Bio-DCPD sales volume in 2025, compared with 19.58% for virgin biomass. Renewable-feedstock cracking and C5 recovery dominated commercial production, while dedicated biomass-derived synthesis remained focused on technology development and industrial scale-up.
Unsaturated polyester resins accounted for 34.24% of global Bio-DCPD sales volume in 2025, followed by hydrocarbon resins at 23.22% and specialty chemical intermediates at 21.79%. These applications collectively represented 79.25% of industrial consumption.
Europe accounted for 52.01% of global Bio-DCPD consumption in 2025, followed by Asia-Pacific at 26.98% and North America at 12.32%. Europe's certified chemical supply chains and Asia-Pacific's established resin and specialty materials industries support different commercial development opportunities.
The three named manufacturers, Shell, Braskem, and ENEOS, represented a combined 81.43% of estimated global Bio-DCPD revenue in 2025. Their competitive positions are associated with integrated petrochemical infrastructure, renewable feedstock access, product certification, technical quality control, and industrial customer relationships.
Bio-DCPD is transitioning from early certified supply arrangements toward broader commercial adoption. Its market development depends on renewable feedstock availability, customer acceptance of certified material attributes, competitive production economics, and the ability to supply consistent industrial product specifications.
Market Trends
The Bio-based Dicyclopentadiene (Bio-DCPD) industry is moving from early commercial qualification toward broader integration with established petrochemical production and downstream chemical manufacturing systems. Conventional DCPD is primarily recovered from C5-containing streams generated during hydrocarbon cracking, making industrial supply closely connected to petrochemical feedstock processing and cyclopentadiene recovery infrastructure. Bio-DCPD development extends this manufacturing platform through renewable naphtha, biogenic waste-derived hydrocarbon intermediates, and certified mass balance accounting. Shell's commercial supply of Bio-circular DCPD for specialty chemical intermediate manufacturing demonstrates the integration of renewable material attributes into an existing industrial chemical value chain. Braskem has developed certified product coverage for Bio and Bio-circular DCPD, while ENEOS has incorporated DCPD into its certified chemical product portfolio. These developments establish a manufacturing and certification foundation across major petrochemical regions, although certified product coverage and realized product-level sales remain distinct operational measures. Technology development is increasingly focused on renewable feedstock pretreatment, steam-cracker compatibility, C5 fractionation efficiency, cyclopentadiene recovery, purification, analytical quality control, and certified chain-of-custody management. Biomass-derived multistep chemical synthesis represents a complementary technology direction, with particular relevance to the production of high-purity cyclic intermediates. Downstream development is expanding from conventional resin feedstocks into specialty alcohols, functional cyclic chemicals, engineered thermosets, and elastomer-related intermediates. During 2026-2032, market expansion will be shaped by the commercial allocation of certified renewable feedstocks, the qualification of additional industrial customers, the development of regional supply networks, and increasingly demanding product quality requirements. The industry's competitive emphasis will progressively shift from the availability of certified products alone toward stable supply, manufacturing efficiency, product purity, cost management, and application-specific technical support.
Market Dynamics
Drivers
The principal growth drivers for Bio-based Dicyclopentadiene (Bio-DCPD) are the integration of renewable raw materials into established chemical manufacturing, the expansion of sustainable procurement programs, and the technical compatibility of DCPD with existing downstream formulations. Unlike a chemically different substitute, Bio-DCPD retains the molecular functionality of conventional DCPD, supporting incorporation into established unsaturated polyester resin, hydrocarbon resin, specialty intermediate, and polymer manufacturing processes. This reduces the fundamental chemistry changes required for raw material substitution, although suppliers must still satisfy product specifications and customer qualification procedures. Demand from packaging, automotive materials, coatings, industrial equipment, and engineered polymer supply chains creates additional incentives for chemical manufacturers to offer products with certified renewable attributes. Existing steam-cracking and C5 recovery infrastructure also provides a manufacturing platform for renewable feedstock integration without requiring every producer to construct a separate DCPD production system. Further development of renewable hydrocarbon sourcing, certified mass balance systems, and industrial product qualification can reduce the incremental operating burden associated with sustainable material supply. High-purity product development supports additional applications requiring tightly controlled impurities and predictable catalytic processing. Over the forecast period, growth will be primarily driven by increased certified product penetration, followed by expansion into higher-specification chemical intermediates and regional supply-chain development.
Restraints
The expansion of Bio-based Dicyclopentadiene (Bio-DCPD) is constrained by renewable feedstock economics, industrial certification requirements, customer price sensitivity, and the technical maturity of alternative production processes. Bio-circular feedstocks such as used cooking oil, animal fats, and eligible biogenic residues are also consumed in renewable diesel, sustainable aviation fuel, and other renewable chemical value chains, creating competition for qualified raw materials. Virgin biomass feedstocks introduce additional exposure to agricultural production cycles, land-use requirements, collection systems, and conversion economics. In mass balance manufacturing, producers must maintain auditable records of feedstock categories, conversion factors, product allocations, sustainability declarations, and the applicable certification boundaries. Downstream commodity resin manufacturers typically operate under strict raw material cost controls, limiting their ability to absorb substantial certified feedstock premiums. Specialty applications offer greater differentiation through chemical specifications but require more demanding technical qualification, including impurity analysis, catalyst compatibility, and reproducible processing performance. Dedicated biomass-derived chemical synthesis faces further challenges involving multiple reaction stages, catalyst stability, hydrogen consumption, separation efficiency, and continuous manufacturing reliability. Improvements in renewable feedstock processing and supply-chain integration can ease these constraints, but feedstock competition and purchasing economics will remain important determinants of Bio-DCPD commercial penetration.
Opportunities
Commercial opportunities for Bio-based Dicyclopentadiene (Bio-DCPD) are concentrated in the certification upgrading of existing C5 chemical assets, specialty intermediate production, high-purity DCPD applications, and the establishment of regional renewable chemical supply networks. Integrated petrochemical producers can combine existing cracking, fractionation, dimerization, and purification systems with certified renewable hydrocarbon feedstocks to develop additional sustainable product offerings. Resin manufacturers can incorporate Bio-DCPD into established unsaturated polyester and hydrocarbon resin formulations, while specialty chemical manufacturers can use the material to produce tricyclodecane-derived alcohols, functional norbornene intermediates, and other cyclic compounds. High-purity Bio-DCPD also creates development opportunities in pDCPD structural materials and selected advanced polymer applications where monomer composition and catalyst compatibility are critical. Europe provides established certified chemical supply relationships, while Asia-Pacific offers a substantial manufacturing base in industrial resins, elastomers, composite materials, and specialty chemicals. China has developed industrial capabilities in C5 processing, chemical separation, resin production, and downstream materials manufacturing, supporting future participation through certified raw material integration and product qualification. The most attractive opportunities combine identifiable industrial customers, established chemical conversion processes, reliable certification arrangements, and differentiated product specifications rather than relying solely on renewable content claims.
Challenges
The Bio-based Dicyclopentadiene (Bio-DCPD) industry faces operating risks associated with renewable feedstock supply, petrochemical production flexibility, customer qualification, certification integrity, and the pace of commercial market expansion. In the short term, renewable naphtha and biogenic residue prices can fluctuate with renewable fuel production, regional collection patterns, logistics, and refinery operating conditions. DCPD supply also depends on the composition of hydrocarbon cracking streams, the availability of recoverable cyclopentadiene, and the operating efficiency of separation and purification equipment. Mass balance-certified products require accurate management of renewable material allocation to prevent double counting and ensure that commercial documentation matches eligible feedstock inputs. Longer-term challenges include the alignment of certification supply capacity with actual customer orders, the narrowing of renewable feedstock premiums, and the industrial qualification of dedicated biomass synthesis technologies. Braskem's 2026 financial restructuring adds capital structure and investment planning considerations to its broader operating environment, without establishing a specific change in Bio-DCPD production. High-purity applications introduce additional requirements concerning catalyst-sensitive impurities, analytical testing, product storage, and downstream processing consistency. Manufacturers capable of coordinating certified feedstock procurement, industrial quality control, product traceability, and customer delivery will be better positioned to manage these risks as the market develops.
Industry Chain Analysis
The Bio-based Dicyclopentadiene (Bio-DCPD) value chain comprises renewable feedstock supply and conversion, industrial DCPD manufacturing, and downstream resin, elastomer, and specialty chemical processing. Upstream inputs include virgin vegetable oils, used cooking oil, eligible animal fats, agricultural residues, forestry byproducts, and biomass-derived chemical intermediates such as furfural. These materials are converted into renewable naphtha, suitable C5 hydrocarbon streams, or dedicated cyclic chemical intermediates through pretreatment, hydroprocessing, catalytic conversion, and purification. Important industrial equipment includes hydrotreating reactors, cracking furnaces, fractionation columns, heat exchangers, catalytic reactors, analytical testing systems, and bulk chemical storage facilities. Feedstock quality and availability affect processing efficiency, product composition, certification costs, and supply continuity. At the midstream manufacturing stage, integrated production typically involves hydrocarbon cracking, recovery of suitable C5 fractions, cyclopentadiene separation, dimerization into DCPD, and final purification. Alternative biomass-derived synthesis involves converting furfural into cyclic intermediates through successive catalytic steps before producing cyclopentadiene and DCPD. Its development requires effective control of reaction selectivity, hydrogen consumption, catalyst performance, intermediate recovery, and continuous processing stability. Quality testing includes gas chromatography, moisture analysis, color determination, and monitoring of aromatic contaminants and reactive codimers. Different downstream applications impose different purity requirements, with high-purity polymerization routes generally demanding tighter impurity control. Downstream customers include unsaturated polyester resin producers, hydrocarbon resin manufacturers, specialty intermediate suppliers, pDCPD processors, and elastomer-related chemical manufacturers. Procurement normally involves supplier assessment, specification approval, laboratory testing, production trials, certification review, and subsequent commercial supply arrangements. Established petrochemical producers benefit from manufacturing integration, experienced process operators, bulk handling systems, and existing industrial sales networks. Dedicated biomass conversion technologies depend more directly on cumulative reaction yields, catalyst operating life, energy efficiency, and process integration. Across the value chain, competitive differentiation is created through feedstock access, efficient chemical conversion, product consistency, documentation reliability, and successful industrial customer qualification.
Segment Insights
By feedstock origin, Bio-based Dicyclopentadiene (Bio-DCPD) is divided into Bio-circular (Biogenic Waste and Residue) and Bio (Virgin Biomass). Bio-circular products accounted for approximately 620 tons, or 80.42% of global sales volume, in 2025, generating USD 1.65 million in revenue and representing 78.57% of the market by value. Virgin biomass-based products accounted for approximately 151 tons, or 19.58% of volume, and USD 0.45 million, or 21.43% of revenue. Their respective average ex-factory prices were approximately USD 2,661 and USD 2,991 per ton. Bio-circular feedstocks primarily involve eligible biological waste and residue streams converted into renewable hydrocarbons for established petrochemical production systems. Virgin biomass-based products draw on agricultural, forestry, or other primary biological resources, with additional variation in pretreatment and conversion requirements. Renewable-feedstock cracking and C5 recovery constitute the main commercial production route, while biomass-derived synthesis offers a separate technical development pathway. Product specifications also differentiate resin-grade, industrial-grade, and high-purity DCPD. Key quality parameters include chemical purity, cyclopentadiene content, codimer composition, aromatic contaminants, water, color, and polymerization compatibility. Bio-DCPD feedstock selection is influenced by material availability, conversion efficiency, certification arrangements, product quality, and commercial procurement requirements. Bio-circular products are expected to maintain a substantial position in commercial supply, while virgin biomass-derived products will benefit from broader renewable chemical processing capabilities and continued development of alternative synthesis technologies.
By application, Bio-based Dicyclopentadiene (Bio-DCPD) consumption is led by unsaturated polyester resins, with approximately 264 tons and 34.24% of global sales volume in 2025. Hydrocarbon resins accounted for 179 tons and 23.22%, followed by specialty chemical intermediates with 168 tons and 21.79%. pDCPD structural materials represented 8.69%, EPDM and other elastomer intermediates 7.13%, and other industrial applications 4.93%. Unsaturated polyester resin manufacturers emphasize raw material composition, moisture, acidity, reaction consistency, and suitability for established formulation processes. Hydrocarbon resin producers require reliable polymerization behavior, predictable softening characteristics, color control, and compatibility with adhesive and coating formulations. Specialty chemical producers impose more demanding requirements concerning intermediate purity, catalytic selectivity, and trace impurities. pDCPD processors depend on consistent monomer quality and compatibility with ring-opening metathesis catalysts, while elastomer intermediate manufacturers prioritize chemical conversion stability and downstream polymerization specifications. Procurement generally involves technical documentation, sample evaluation, production trials, supplier audits, and commercial qualification. Mature resin applications provide the principal opportunity for wider industrial substitution, whereas specialty intermediates and engineered structural materials support higher-specification product development. The balance between these applications will shape future product grade requirements, technical support practices, manufacturing costs, and customer relationships.
Downstream Market Opportunities
The strongest downstream opportunities for Bio-based Dicyclopentadiene (Bio-DCPD) combine established industrial resin manufacturing with the development of higher-performance chemical intermediates and engineered polymer systems. Unsaturated polyester resins provide an application base across construction, transportation, marine products, industrial equipment, and reinforced composites. Manufacturers can combine Bio-DCPD with other certified raw materials to develop renewable-attributed thermoset products while retaining established formulation and processing methods. Hydrocarbon resins offer additional opportunities in adhesives, packaging, industrial coatings, sealants, and polymer modification, supported by existing C5 hydrocarbon processing capabilities. Specialty chemical intermediates provide further differentiation through tricyclodecane alcohols, functional norbornenes, cyclic compounds, and related materials used in technical polymers, advanced coatings, and electronic applications. High-purity Bio-DCPD is relevant to pDCPD structural materials used in industrial equipment, agricultural machinery, corrosion-resistant components, and other engineered applications. EPDM-related intermediates offer additional market access through automotive sealing, roofing, cable insulation, and industrial rubber supply chains. The largest demand expansion will be associated with certified raw material penetration in established applications, while specialty chemical development will place greater emphasis on product purity, controlled impurities, and application-specific customer qualification.
Regional Insights
Bio-based Dicyclopentadiene (Bio-DCPD) consumption is concentrated in Europe, Asia-Pacific, and North America. Europe accounted for approximately 401 tons, or 52.01% of global sales volume, in 2025, supported by established petrochemical processing, certified chemical supply chains, and specialty materials manufacturing. Germany and surrounding industrial regions provide important downstream chemical processing capabilities. Asia-Pacific accounted for 208 tons and 26.98%, with China and Japan occupying important positions in the regional industrial supply chain. China has established manufacturing capabilities in C5 separation, industrial resins, adhesives, composites, elastomers, and chemical engineering, while Japan has developed expertise in high-purity DCPD processing and specialty chemical manufacturing. ENEOS has incorporated DCPD into its certified chemical product portfolio. North America represented 95 tons and 12.32% of estimated global consumption, supported by industrial resins, specialty chemicals, and structural polymer applications. Latin America accounted for 39 tons and 5.06%, with Brazil providing a substantial renewable feedstock and petrochemical manufacturing base. The Middle East and Africa contributed 28 tons and 3.63%, associated with regional resin processing and chemical distribution. By 2032, Asia-Pacific's projected volume share reaches 36.17%, compared with Europe's 43.82%, narrowing the difference between the two largest regional markets. Regional competitiveness will increasingly depend on certified feedstock availability, local industrial customer qualification, product specification control, and reliable chemical logistics.
Competitive Landscape Analysis
The global Bio-based Dicyclopentadiene (Bio-DCPD) market has a concentrated competitive structure, with the Top 3 named manufacturers-Shell, Braskem, and ENEOS-accounting for 81.43% of estimated global manufacturer sales revenue in 2025. Shell generated approximately USD 1.07 million in Bio-DCPD revenue, representing 50.95% of the global total. Braskem contributed USD 0.37 million, or 17.62%, and ENEOS generated USD 0.27 million, or 12.86%. Other manufacturers collectively accounted for USD 0.39 million, or 18.57%. Shell benefits from established chemical manufacturing infrastructure, European industrial customer relationships, and demonstrated commercial supply of certified Bio-circular DCPD. Braskem has integrated petrochemical operations and experience with Bio, Bio-circular, and Circular material certification, supporting the development of renewable-attributed product portfolios. ENEOS operates within Japan's integrated refinery and chemical manufacturing system and maintains relevant product certification and industrial materials sales capabilities. Competitive differentiation in Bio-DCPD extends beyond conventional DCPD production capacity to include sustainable feedstock sourcing, mass balance accounting, chemical purity control, product consistency, customer qualification, and supply reliability. As additional established C5 chemical manufacturers introduce certified products, competition will increasingly involve feedstock procurement economics, purification performance, product grade specialization, and regional commercial relationships. New entrants can establish positions through certified feedstock partnerships, specialized DCPD purification, high-purity product development, and targeted industrial applications rather than competing solely through large-scale cracking capacity.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bio-based Dicyclopentadiene (Bio-DCPD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-based Dicyclopentadiene (Bio-DCPD).
The Bio-based Dicyclopentadiene (Bio-DCPD) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2025 as the base year, with history and forecast data for the period from 2021 to 2032. This report segments the global Bio-based Dicyclopentadiene (Bio-DCPD) market comprehensively. Regional market sizes, concerning products by Feedstock, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report helps readers understand competition within the industry and formulate competitive strategies to improve profitability. The report also focuses on the competitive landscape of the global Bio-based Dicyclopentadiene (Bio-DCPD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operating performance, expansions, acquisitions, etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Bio-based Dicyclopentadiene (Bio-DCPD) segments by manufacturers, by Feedstock, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2021-2025, 2026-2032), considering 2025 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
Segment by Feedstock
Segment by Production Route
Segment by Application
By Region
Chapter Outline
Chapter One: Introduces the study scope of this report, executive summary of market segments by Feedstock, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter Two: Detailed analysis of the competitive landscape of Bio-based Dicyclopentadiene (Bio-DCPD) manufacturers, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales and revenue of Bio-based Dicyclopentadiene (Bio-DCPD) at the regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channels, distributors, and customers.
Chapter Thirteen: Research Findings and Conclusion.